421 related articles for article (PubMed ID: 7391970)
1. CL-845 (pirmenol hydrochloride): a new orally effective long-acting antiarrhythmic agent.
Steffe TJ; Mertz TE; Hastings SG; Potoczak RE; Kaplan HR
J Pharmacol Exp Ther; 1980 Jul; 214(1):50-7. PubMed ID: 7391970
[No Abstract] [Full Text] [Related]
2. Antiarrhythmic actions of two new beta adrenergic blocking agents, Kö 1313 and Kö 1366.
Baum T; Rowles G; Shropshire AT
J Pharmacol Exp Ther; 1971 Feb; 176(2):350-60. PubMed ID: 4105546
[No Abstract] [Full Text] [Related]
3. Pirmenol hydrochloride (CI-845) and reference antiarrhythmic agents: effects on early ventricular arrhythmias after acute coronary artery ligation in anesthetized rats.
Mertz TE; Kaplan HR
J Pharmacol Exp Ther; 1982 Nov; 223(2):580-6. PubMed ID: 7131307
[TBL] [Abstract][Full Text] [Related]
4. Antiarrhythmic, hemodynamic and cardiac electrophysiological evaluation of N-(2,6-dimethylphenyl)-N'-[3-(1-methylethylamino)propyl]urea (Wy-42,362).
Bergey JL; Sulkowski T; Much DR; Wendt RL
Arzneimittelforschung; 1983; 33(9):1258-68. PubMed ID: 6685506
[TBL] [Abstract][Full Text] [Related]
5. [Utilization of anti-arrhythmic drugs].
Perrenoud JJ
Schweiz Med Wochenschr; 1980 Jul; 110(29):1090-6. PubMed ID: 6999615
[TBL] [Abstract][Full Text] [Related]
6. Anti-arrhythmic action of beta-adrenergic receptor blocking agents.
Somani P; Kumakura S
Recent Adv Stud Cardiac Struct Metab; 1973; 3():367-85. PubMed ID: 4806661
[No Abstract] [Full Text] [Related]
7. [Effects of lorcainide, a new antiarrhythmic agent, on experimental cardiac arrhythmias].
Fukuda H; Goto M; Kondo M; Uchigasaki T; Sekino Y
Nihon Yakurigaku Zasshi; 1983 Feb; 81(2):115-26. PubMed ID: 6852683
[TBL] [Abstract][Full Text] [Related]
8. Antiarrhythmic, electrophysiologic and hemodynamic effects of ACC-9358.
Brown BS; Calzadilla SV; Diemer MJ; Hartman JC; Reynolds RD
J Pharmacol Exp Ther; 1987 Dec; 243(3):1225-34. PubMed ID: 3694532
[TBL] [Abstract][Full Text] [Related]
9. [Bonnecor--a new anti-arrhythmia preparation].
Berdiaev SIu; Lyskovtsev VV; Senova ZP; Darinskiĭ NV; Grigor'eva EK; Tolmacheva EA; Turilova AI; Gritsenko AN; Kaverina NV
Farmakol Toksikol; 1990; 53(3):33-6. PubMed ID: 2387376
[TBL] [Abstract][Full Text] [Related]
10. [The effect of naloxone on rhythm disorders and on the conduction system of the heart].
Shliakhto EV; Zaĭtsev AA; Panov AV; Ardashev AV; Nifontov EM; Kashina EA; Kazarin VV; Ivanov VV
Eksp Klin Farmakol; 1996; 59(3):34-6. PubMed ID: 8974581
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the antiarrhythmic profile of the new class I agent diprafenone.
Gülker H; Thale J; Olbing B; Heuer H; Frenking B; Bender F
Arzneimittelforschung; 1985; 35(9):1387-93. PubMed ID: 4084340
[TBL] [Abstract][Full Text] [Related]
12. [Experimental anti-arrhythmic effects of a new beta-adrenergic receptor blocking agent, dl-l-(tert. butylamino)-3-[(2-propinyloxy)phenoxy]2-propanol hydrochloride (dl Kö 1400-Cl)].
Matsubara I; Hashimoto K; Katano Y; Tsukada T; Matsuda H
Nihon Yakurigaku Zasshi; 1976 Jul; 72(5):557-71. PubMed ID: 11153
[TBL] [Abstract][Full Text] [Related]
13. Antiarrhythmic, electrophysiologic and hemodynamic effects of lorcainide.
Carmeliet E; Janssen PA; Marsboom R; Van Nueten JM; Xhonneux R
Arch Int Pharmacodyn Ther; 1978 Jan; 231(1):104-30. PubMed ID: 637616
[TBL] [Abstract][Full Text] [Related]
14. [Experimental anti-arrhythmic action of perhexiline].
Sánchez-Pérez S; Pastelín G; Valenzuela F; Méndez R
Arch Inst Cardiol Mex; 1976; 46(6):696-706. PubMed ID: 799493
[TBL] [Abstract][Full Text] [Related]
15. Pirmenol hydrochloride (CI-845): antiarrhythmic profile in coronary artery ligated conscious dogs.
Mertz TE; Steffe TJ
J Cardiovasc Pharmacol; 1980; 2(5):527-41. PubMed ID: 6157947
[TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic properties of MJ 9067 in acute animal models.
Byrne JE; Gomoll AW; McKinney GR
J Pharmacol Exp Ther; 1977 Jan; 200(1):147-54. PubMed ID: 401883
[TBL] [Abstract][Full Text] [Related]
17. Anti-arrhythmic properties of 1,5-dimorpholino-3-(1-naphthyl)-pentane (DA 1686).
Bianchi C; Sanna GP; Turba C
Arzneimittelforschung; 1968 Jul; 18(7):845-50. PubMed ID: 5755831
[No Abstract] [Full Text] [Related]
18. Pharmacological investigation of a new anti-arrhythmic agent, GYKI-23 107.
Varró A; Rabloczky G; Jaszlits L; Kürthy M; Zubovics Z; Toldy L
Drugs Exp Clin Res; 1987; 13(1):21-8. PubMed ID: 3595441
[TBL] [Abstract][Full Text] [Related]
19. Antiarrhythmic action of the new calcium antagonist [1,2,5-trimethyl-4-phenyl-4-beta-(N-cyanoethyl-N-4'-methoxybenzyl) -ethylamino]piperidine dihydrochloride.
Alexanian AR; Arutyunian NS; Galoyan AA
Arzneimittelforschung; 1996 Dec; 46(12):1110-3. PubMed ID: 9006783
[TBL] [Abstract][Full Text] [Related]
20. [Effect of a new antiarrhythmic drug, bunaftine, on the bundle of His].
Scibilia G; Bonatti V; Pavarani A; Tagliavini S; Botti G
Cardiol Prat; 1973; 24(1):79-84. PubMed ID: 4575451
[No Abstract] [Full Text] [Related]
[Next] [New Search]
